Vaughan & Co Securities
PFE icon

Vaughan & Co Securities’s Pfizer PFE Stock Holding History

Vaughan & Co Securities’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-14,258
Closed -$343K – 65
2026
Q2 		$343K Sell
14,258
-1,153
-7% -$30.2K 0.16% 49
2026
Q1 		$433K Sell
15,411
-433
-3% -$11.5K 0.22% 46
2025
Q4 		$395K Sell
15,844
-495
-3% -$12.5K 0.2% 45
2025
Q3 		$416K Sell
16,339
-10,453
-39% -$258K 0.22% 46
2025
Q2 		$649K Sell
26,792
-74
-0.3% -$1.73K 0.37% 32
2025
Q1 		$681K Hold
26,866
– – 0.42% 33
2024
Q4 		$713K Sell
26,866
-289
-1% -$7.84K 0.43% 31
2024
Q3 		$786K Sell
27,155
-415
-2% -$12.1K 0.46% 28
2024
Q2 		$771K Buy
27,570
+8,370
+44% +$230K 0.49% 21
2024
Q1 		$533K Sell
19,200
-1,718
-8% -$47.7K 0.34% 44
2023
Q4 		$602K Buy
20,918
+8,480
+68% +$256K 0.4% 41
2023
Q3 		$413K Hold
12,438
– – 0.31% 46
2023
Q2 		$456K Hold
12,438
– – 0.32% 47
2023
Q1 		$507K Buy
12,438
+381
+3% +$16.5K 0.38% 46
2022
Q4 		$618K Sell
12,057
-298
-2% -$14.3K 0.49% 36
2022
Q3 		$541K Sell
12,355
-48
-0.4% -$2.33K 0.47% 37
2022
Q2 		$650K Hold
12,403
– – 0.52% 32
2022
Q1 		$642K Sell
12,403
-446
-3% -$23.1K 0.44% 38
2021
Q4 		$759K Sell
12,849
-336
-3% -$16.6K 0.51% 23
2021
Q3 		$567K Sell
13,185
-211
-2% -$9.35K 0.42% 37
2021
Q2 		$525K Hold
13,396
– – 0.39% 38
2021
Q1 		$485K Hold
13,396
– – 0.39% 39
2020
Q4 		$493K Sell
13,396
-1,072
-7% -$39.3K 0.44% 26
2020
Q3 		$504K Sell
14,468
-483
-3% -$16.9K 0.53% 22
2020
Q2 		$464K Hold
14,951
– – 0.51% 28
2020
Q1 		$463K Hold
14,951
– – 0.59% 21
2019
Q4 		$556K Buy
+14,951
New +$533K 0.5% 34

Other funds holding PFE

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Fort Washington Investment Advisors
Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

Vaughan & Co Securities's PFE Position: Q3 2026 in Review

Vaughan & Co Securities sold out of Pfizer (PFE) in Q3 2026, closing a stake of 14,258 shares — an estimated $343K sold.

Vaughan & Co Securities first reported a position in PFE in Q4 2019 and held it in 27 quarters. The position peaked at $786K in Q3 2024. 881 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Vaughan & Co Securities reported no remaining Pfizer position as of Q3 2026 after selling out during the quarter.
  • Vaughan & Co Securities sold 14,258 Pfizer shares in Q3 2026, an estimated $343K.
  • Vaughan & Co Securities first reported a position in Pfizer in Q4 2019 and held it in 27 quarters.
  • Vaughan & Co Securities's Pfizer position peaked at $786K in Q3 2024.
  • 881 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Vaughan & Co Securities's 13F filing for Q3 2026, filed 23 Oct 2026.